Cosmos Health Launches Strategic Partnership With Prime Ledger to Transform $300M Treasury and Tokenize IP Assets
MWN-AI** Summary
Cosmos Health Inc. (NASDAQ:COSM), a global healthcare group, has announced a strategic partnership with Prime Ledger LLC, a provider of blockchain infrastructure services, to enhance its financial operations through a comprehensive digital transformation. The partnership involves overseeing Cosmos Health's $300 million treasury and tokenizing its high-value intellectual property (IP) assets.
The initial phase of this collaboration will focus on establishing a secure framework for Digital Asset Treasury (DAT) management. Prime Ledger will implement sophisticated controls and reporting systems to improve efficiency and security, while also managing risks and yield from Cosmos Health's treasury operations. A significant aspect of the partnership is the tokenization of various IP assets, which will enable the company to access new funding channels based on its portfolio of healthcare innovations.
Additionally, the agreement will integrate Cosmos Health's data infrastructure with Prime Ledger's existing capabilities, allowing for better management of on-chain and off-chain data. This integration is crucial for financial reporting, regulatory compliance, and real-time performance analytics.
CEO Greg Siokas highlighted that this partnership marks a pivotal evolution for Cosmos Health, positioning it to lead in the digital economy of the healthcare sector. By digitizing treasury operations and leveraging IP tokenization, the company aims to enhance efficiency and create new growth opportunities. Meanwhile, Prime Ledger's CEO, Robert Hoffman, emphasized the blend of financial security and blockchain expertise needed to manage such a significant treasury and tokenize unique IP assets.
The collaboration will begin in Q4 2025, concentrating on strategy and regulatory mapping for the treasury and tokenization platforms. This initiative is set to create a new standard for digital finance within the global healthcare industry, showcasing innovative solutions in asset management and investment.
MWN-AI** Analysis
Cosmos Health Inc. (NASDAQ: COSM) has ignited market interest with its announcement of a strategic partnership with Prime Ledger, aimed at transforming its financial operations through digital asset management and the tokenization of intellectual property. This $300 million treasury initiative positions Cosmos Health at the forefront of the healthcare sector’s digital transformation, an increasingly critical area as healthcare organizations adapt to modern financial technologies.
As a financial analyst, I advise potential investors to closely examine Cosmos Health’s trajectory following this collaboration. The partnership with Prime Ledger signifies a proactive approach to modernizing their treasury management and enhancing operational efficiency. Given the increasing importance of blockchain and digital asset strategies, this move could unlock significant growth opportunities for the company, particularly through the monetization of its extensive IP portfolio—an initiative that may attract new investors and partnerships.
From a risk perspective, while the aggressive expansion into digital finance indicates innovative thinking, it also introduces uncertainty. As highlighted by the company’s forward-looking statements, risks include the ability to execute on their strategy and external challenges such as geopolitical issues and market volatility. Investors should remain vigilant to these potential pitfalls.
Moreover, with healthcare's ongoing digital transformation, establishing a compliant and secure Digital Asset Treasury is crucial. Cosmos Health’s phased approach, starting with strategy and regulatory mapping, reflects due diligence—a positive indicator of management’s commitment to thoroughness.
In conclusion, Cosmos Health's newly announced strategies present an exciting opportunity for growth, especially for those interested in the intersection of healthcare and technology. However, prospective investors should weigh the potential for innovation against the inherent risks in such a dynamic market landscape. Careful monitoring of the implementation of these initiatives will be key to gauging their success.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
CHICAGO, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced a long-term strategic partnership with Prime Ledger LLC ("Prime Ledger"), a leading provider of blockchain infrastructure services and digital asset treasury management. This multi-phase agreement is centered on a comprehensive digital transformation of Cosmos Health’s financial operations, including participating in the management of its $300,000,000 treasury facility and the tokenization of high-value intellectual property (IP).
This collaboration will be executed in several phases, beginning with the establishment of a compliant and secure framework for Digital Asset Treasury (DAT) management. Prime Ledger will help oversee Cosmos Health’s $300M treasury, implementing sophisticated controls, protocol, and reporting systems to enhance efficiency and security while managing risk, yield and income in its corporate treasury operations.
A cornerstone of the partnership involves the tokenization of various IP assets owned by Cosmos Health. Prime Ledger will design and deploy a token issuance platform, enabling Cosmos Health to unlock new capitalization channels and model investments based on its extensive portfolio of healthcare and wellness innovations.
Furthermore, the agreement includes the integration of Cosmos Health’s data infrastructure using Prime Ledger's existing relationship with Conduit Network. This will allow Cosmos Health to more effectively manage its complex on-chain and off-chain data (i.e. data that is permanently recorded, stored, and verifiable on a public blockchain's distributed ledger and data that is external to a blockchain), consolidating flows for financial reporting, regulatory compliance, and real-time performance analytics.
Greg Siokas, CEO of Cosmos Health, stated: “This partnership with Prime Ledger is a pivotal step in our evolution, positioning Cosmos Health at the forefront of the digital economy in the healthcare sector. By digitizing our treasury and tokenizing our valuable IP, we are not just enhancing efficiency; we are building new pathways for growth and innovation. Prime Ledger’s expertise provides the secure and scalable infrastructure we need to achieve these strategic goals.”
Robert Hoffman, CEO of Prime Ledger, commented: “We are honoured that Cosmos Health has selected Prime Ledger for this transformative initiative. Managing a significant treasury and tokenizing unique IP requires a blend of deep financial security, data integrity, and blockchain expertise. Our platforms are built for this exact purpose. We are fully committed to supporting Cosmos's long-term vision and setting a new standard for digital finance in the global healthcare industry."
The initial phase of the engagement is set to commence in Q4 2025 and will focus on strategy, regulatory mapping, and the architectural design of the treasury and tokenization platforms.
About Prime Ledger LLC
Prime Ledger LLC is a premier provider of digital asset and blockchain infrastructure services. The firm specializes in secure digital asset treasury management, full-lifecycle asset tokenization, and big data integration for enterprise clients, enabling corporations to navigate the digital finance ecosystem.
About Cosmos Health Inc.
Cosmos Health Inc. (Nasdaq:COSM), incorporated in 2009 in Nevada, is a diversified, vertically integrated global healthcare group. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life®, Mediterranation®, bio-bebe®, C-Sept® and C-Scrub®. Through its subsidiary Cana Laboratories S.A., licensed under European Good Manufacturing Practices (GMP) and certified by the European Medicines Agency (EMA), it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. Cosmos Health also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and OTC medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the UK. Furthermore, the Company has established R&D partnerships targeting major health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of novel patented nutraceuticals, specialized root extracts, proprietary complex generics, and innovative OTC products. Cosmos Health has also entered the telehealth space through the acquisition of ZipDoctor, Inc., based in Texas, USA. With a global distribution platform, the Company is currently expanding throughout Europe, Asia, and North America, and has offices and distribution centers in Thessaloniki and Athens, Greece, and in Harlow, UK. More information is available at www.cosmoshealthinc.com , www.skypremiumlife.com , www.cana.gr , www.zipdoctor.co , www.cloudscreen.gr , as well as LinkedIn and X .
Forward-Looking Statements
With the exception of the historical information contained in this news release, the matters described herein may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Words such as “believes,” “expects,” “anticipates,” “intends,” “projects,” “estimates,” “plans,” and similar expressions, or future or conditional verbs such as “will,” “should,” “would,” “may,” and “could,” generally identify forward-looking statements, although not all forward-looking statements contain these words. These statements involve risks and uncertainties that may individually or materially affect the matters discussed herein for a variety of reasons outside the Company’s control, including, but not limited to: the Company’s ability to raise sufficient financing to implement its business plan; the effectiveness of its digital asset strategies, including accumulation and yield-generating activities; the impact of the war in Ukraine on the Company’s business, operations, and the economy in general; and the Company’s ability to successfully develop and commercialize its proprietary products and technologies. Readers are cautioned not to place undue reliance on these forward-looking statements, as actual results could differ materially from those anticipated. Readers are encouraged to review the risk factors set forth in the Company’s filings with the SEC, which are available at the SEC’s website ( www.sec.gov ). The Company disclaims any obligation to update or revise forward-looking statements, whether as a result of any new information, future events, or otherwise.
Investor Relations Contact:
BDG Communications
cosm@bdgcommunications.com
Disclaimer
This electronic content is for the purposes of solicitation subscriptions for Market Wire News. Market Wire News expects to generate new advertisement revenue resulting from the distribution of this electronic content. The amount of which is unknown at this time. Market Wire News is not a registered investment adviser or broker-dealer. This electronic content does not provide a professional analysis of a COSM financial position. COSM financial position and all other information regarding the featured Company should be verified directly with COSM. This electronic content is provided as an information service only, and any statements and opinions in this electronic content should not be construed as an offer or solicitation to buy or sell any security. Market Wire News accepts no liability for any loss arising from an investor's reliance on or use of this electronic content. An investment in COSM is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Market Wire News does not own, buy, sell or plans to own, buy, sell, and of COSM shares. This electronic content contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Compensation: Market Wire News and its affiliates has received six thousand dollars for Market Wire News advertising services from Relqo Media LLC for Brand Awareness Distribution, Corporate Communications, News, Press Release Enhancement and Social Media Solutions starting 2026-05-31 and ending 2026-06-05 provided by Market Wire News. To date, we have received a total of six thousand dollars. Please read our full disclaimer for compensation and more detailed information.
FAQ**
How does Cosmos Holdings Inc. COSM plan to utilize the tokenization of its intellectual property to create new capitalization channels, and what specific IP assets are being considered for this initiative?
What measures will Cosmos Holdings Inc. COSM take to ensure the security and compliance of its treasury management under the partnership with Prime Ledger LLC, particularly in relation to regulatory mapping?
How will the digital transformation of Cosmos Holdings Inc. COSM’s financial operations impact its overall business strategy and operational efficiency in the healthcare sector?
What potential risks and uncertainties does Cosmos Holdings Inc. COSM foresee in implementing its digital asset strategies, particularly concerning the complex interplay of regulatory compliance and market dynamics?
**MWN-AI FAQ is based on asking OpenAI questions about Cosmos Health Inc. (NASDAQ: COSM).
NASDAQ: COSM
COSM Trading
-3.36% G/L:
$0.2505 Last:
367,675 Volume:
$0.264 Open:
